According to a TAU researcher, neurons in the nose could be the key to early, fast, and accurate diagnosis of the debilitating mental illness, schizophrenia.
Because physiological evidence confirming the disease can only be gathered from the brain during an autopsy, mental health professionals have had to rely on a battery of psychological evaluations to diagnose their patients.
Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.
Advertisement
Now, Dr. Noam Shomron and Prof. Ruth Navon of Tel Aviv University's Sackler Faculty of Medicine, together with PhD student Eyal Mor from Dr. Shomron's lab and Prof. Akira Sawa of Johns Hopkins Hospital in Baltimore, Maryland, have discovered a method for physical diagnosis - by collecting tissue from the nose through a simple biopsy.
Surprisingly, collecting and sequencing neurons from the nose may lead to "more sure-fire" diagnostic capabilities than ever before, Dr. Shomron said.
This finding could not only lead to a more accurate diagnosis, it may also permit the crucial, early detection of the disease, giving rise to vastly improved treatment overall.
Until now, biomarkers for schizophrenia had only been found in the neuron cells of the brain, which can't be collected before death. By that point it's obviously too late to do the patient any good, said Dr. Shomron.
Instead, psychiatrists depend on psychological evaluations for diagnosis, including interviews with the patient and reports by family and friends.
For a solution to this diagnostic dilemma, the researchers turned to the olfactory system, which includes neurons located on the upper part of the inner nose. Researchers at Johns Hopkins University collected samples of olfactory neurons from patients diagnosed with schizophrenia and a control group of non-affected individuals, then sent them to Dr. Shomron's TAU lab.
Dr. Shomron and his fellow researchers applied a high-throughput technology to these samples, studying the microRNA of the olfactory neurons. Within these molecules, which help to regulate our genetic code, they were able to identify a microRNA, which is highly elevated in those with schizophrenia, compared to individuals who do not have the disease.
Further research revealed that this particular microRNA controls genes associated with the generation of neurons.
In practice, material for biopsy could be collected through a quick and easy outpatient procedure, using a local anesthetic, said Dr. Shomron. And with microRNA profiling results ready in a matter of hours, this method could evolve into a relatively simple and accurate test to diagnose a very complicated illness.
Though there is much more to investigate, Dr. Shomron has high hopes for this diagnostic method.
This finding was reported in the journal Neurobiology of Disease.
Source: ANI
Advertisement
This finding could not only lead to a more accurate diagnosis, it may also permit the crucial, early detection of the disease, giving rise to vastly improved treatment overall.
Until now, biomarkers for schizophrenia had only been found in the neuron cells of the brain, which can't be collected before death. By that point it's obviously too late to do the patient any good, said Dr. Shomron.
Instead, psychiatrists depend on psychological evaluations for diagnosis, including interviews with the patient and reports by family and friends.
For a solution to this diagnostic dilemma, the researchers turned to the olfactory system, which includes neurons located on the upper part of the inner nose. Researchers at Johns Hopkins University collected samples of olfactory neurons from patients diagnosed with schizophrenia and a control group of non-affected individuals, then sent them to Dr. Shomron's TAU lab.
Dr. Shomron and his fellow researchers applied a high-throughput technology to these samples, studying the microRNA of the olfactory neurons. Within these molecules, which help to regulate our genetic code, they were able to identify a microRNA, which is highly elevated in those with schizophrenia, compared to individuals who do not have the disease.
Further research revealed that this particular microRNA controls genes associated with the generation of neurons.
In practice, material for biopsy could be collected through a quick and easy outpatient procedure, using a local anesthetic, said Dr. Shomron. And with microRNA profiling results ready in a matter of hours, this method could evolve into a relatively simple and accurate test to diagnose a very complicated illness.
Though there is much more to investigate, Dr. Shomron has high hopes for this diagnostic method.
This finding was reported in the journal Neurobiology of Disease.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Mental Health News
Proenkephalin, a chemical molecule present in the brain's hypothalamus, is linked to emotionally driven overeating in response to stress and threats.
Americans experience stress over the holidays, due to inflation, world affairs, rising flu and COVID-19 instances, and previous holiday melt-down.
Evaluating stress levels to improve employee mental health and sleep has shown to be effective in enhancing work performance.
Excessive inflammation and the loss of critical brain protection mechanisms have been found as a potential player in suicide risk.
The hippocampal taurine concentration is 20% lower in women affected by depression, stated new research.